{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:22:13Z","timestamp":1778865733151,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"50","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Scientific Foundation of China","doi-asserted-by":"crossref","award":["81471888"],"award-info":[{"award-number":["81471888"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.10.044","type":"journal-article","created":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T14:45:51Z","timestamp":1478184351000},"page":"6358-6366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine"],"prefix":"10.1016","volume":"34","author":[{"given":"Cheng","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenzhen","family":"Diao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaqin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2016.10.044_b0005","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.cell.2006.01.034","article-title":"Anti-immunology: evasion of the host immune system by bacterial and viral pathogens","volume":"124","author":"Finlay","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2016.10.044_b0010","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.3390\/v3101870","article-title":"Feline immunodeficiency virus (FIV) neutralization: a review","volume":"3","author":"Hosie","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2016.10.044_b0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm.1949","article-title":"Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?","volume":"15","author":"Stamatatos","year":"2009","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2016.10.044_b0020","doi-asserted-by":"crossref","first-page":"e65548","DOI":"10.1371\/journal.pone.0065548","article-title":"Signal peptide cleavage from GP5 of PRRSV: a minor fraction of molecules retains the decoy epitope, a presumed molecular cause for viral persistence","volume":"8","author":"Thaa","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.10.044_b0025","doi-asserted-by":"crossref","first-page":"e705","DOI":"10.1371\/journal.pone.0000705","article-title":"The murine gammaherpesvirus-68 gp150 acts as an immunogenic decoy to limit virion neutralization","volume":"2","author":"Gillet","year":"2007","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2016.10.044_b0030","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1189\/jlb.4RI0214-126R","article-title":"Immune control and failure in HCV infection\u2013tipping the balance","volume":"96","author":"Dustin","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.vaccine.2016.10.044_b0035","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1128\/CVI.00035-12","article-title":"Xenoepitope substitution avoids deceptive imprinting and broadens the immune response to foot-and-mouth disease virus","volume":"19","author":"Szczepanek","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2016.10.044_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12985-015-0361-x","article-title":"Revisiting the taxonomical classification of porcine circovirus type 2 (PCV2): still a real challenge","volume":"12","author":"Franzo","year":"2015","journal-title":"Virol J"},{"issue":"2","key":"10.1016\/j.vaccine.2016.10.044_b0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.prevetmed.2013.02.010","article-title":"Cost of post-weaning multi-systemic wasting syndrome and porcine circovirus type-2 subclinical infection in England \u2013 an economic disease model","volume":"110","author":"Alarcon","year":"2013","journal-title":"Prev Vet Med"},{"issue":"1","key":"10.1016\/j.vaccine.2016.10.044_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-014-1099-z","article-title":"Current understanding of genomic DNA of porcine circovirus type 2","volume":"49","author":"Lv","year":"2014","journal-title":"Virus Genes"},{"issue":"15","key":"10.1016\/j.vaccine.2016.10.044_b0055","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1128\/JVI.00737-11","article-title":"The 2.3-angstrom structure of porcine circovirus 2","volume":"85","author":"Khayat","year":"2011","journal-title":"J Virol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2016.10.044_b0060","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1099\/0022-1317-81-7-1815","article-title":"Differential recognition of ORF2 protein from type 1 and type 2 porcine circoviruses and identification of immunorelevant epitopes","volume":"81","author":"Mah\u00e9","year":"2000","journal-title":"J Gen Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2016.10.044_b0065","doi-asserted-by":"crossref","first-page":"8135","DOI":"10.1128\/JVI.78.15.8135-8145.2004","article-title":"Epitope mapping of the major capsid protein of type 2 porcine circovirus (PCV2) by using chimeric PCV1 and PCV2","volume":"78","author":"Lekcharoensuk","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2016.10.044_b0070","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/CVI.00418-10","article-title":"Antibody recognition of porcine circovirus type 2 capsid protein epitopes after vaccination, infection, and disease","volume":"18","author":"Trible","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"24","key":"10.1016\/j.vaccine.2016.10.044_b0075","doi-asserted-by":"crossref","first-page":"13508","DOI":"10.1128\/JVI.01763-12","article-title":"Recognition of the different structural forms of the capsid protein determines the outcome following infection with porcine circovirus type 2","volume":"86","author":"Trible","year":"2012","journal-title":"J Virol"},{"issue":"27","key":"10.1016\/j.vaccine.2016.10.044_b0080","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1016\/j.vaccine.2012.04.022","article-title":"Antibody responses following vaccination versus infection in a porcine circovirus-type 2 (PCV2) disease model show distinct differences in virus neutralization and epitope recognition","volume":"30","author":"Trible","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2016.10.044_b0085","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000442751","article-title":"Detection of the assembly and disassembly of PCV2b virus-like particles using fluorescence spectroscopy analysis","volume":"58","author":"Fang","year":"2015","journal-title":"Intervirology"},{"key":"10.1016\/j.vaccine.2016.10.044_b0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(90)90029-U","article-title":"Removal of endotoxin from protein solutions by phase separation using Triton X-114","volume":"132","author":"Aida","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2016.10.044_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-61779-821-4_33","article-title":"Extraction of proteins from gels: a brief review","volume":"869","author":"Kurien","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"19","key":"10.1016\/j.vaccine.2016.10.044_b0100","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1016\/j.vaccine.2010.02.072","article-title":"A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle","volume":"28","author":"He","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.044_b0105","first-page":"233","article-title":"Detoxified exotoxin A enhanced the immune response of a porcine circovirus type 2 (PCV2) ORF2 recombinant protein","volume":"37","author":"Chen","year":"2011","journal-title":"Taiwan Vet J"},{"issue":"1","key":"10.1016\/j.vaccine.2016.10.044_b0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jbiotec.2007.09.015","article-title":"Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA","volume":"133","author":"Wu","year":"2008","journal-title":"J Biotechnol"},{"issue":"42","key":"10.1016\/j.vaccine.2016.10.044_b0115","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/j.vaccine.2009.07.061","article-title":"The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts","volume":"27","author":"Bucarey","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.10.044_b0120","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","article-title":"Porcine circovirus type 2 (PCV2): pathogenesis and interaction with the immune system","volume":"1","author":"Meng","year":"2013","journal-title":"Annu Rev Anim Biosci"},{"issue":"1","key":"10.1016\/j.vaccine.2016.10.044_b0125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1090-0233(03)00182-5","article-title":"Postweaning multisystemic wasting syndrome: a review of aetiology, diagnosis and pathology","volume":"168","author":"Chae","year":"2004","journal-title":"Vet J"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2016.10.044_b0130","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virusres.2011.09.014","article-title":"Concurrent infections are important for expression of porcine circovirus associated disease","volume":"164","author":"Opriessnig","year":"2012","journal-title":"Virus Res"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16309793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T07:42:14Z","timestamp":1568533334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16309793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16309793"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replacing the decoy epitope of PCV2b capsid protein with a protective epitope enhances efficacy of PCV2b vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}